What are the most valued startups in the deep tech market?
This monthly refreshed ranking tracks the most valuable startups and technology companies in the deep tech market.

In our updated market reports, you will find everything you need
The deep tech market includes companies building technologies based on advanced engineering, scientific research and difficult-to-replicate intellectual property.
This ranking covers major areas such as space technology, robotics, quantum computing, semiconductors, biotechnology, energy storage and autonomous systems.
We update this list every month to reflect new funding rounds, public market movements, acquisitions and other valuation signals.
A quick summary table
| Metric | Value |
|---|---|
| Most valuable deep tech company | SpaceX, $2.0T |
| Second most valuable deep tech company | Blue Origin, $120.0B–$140.0B |
| Median deep tech valuation | Approximately $2.0B |
| Share of deep tech valuation captured by the top 10 | Approximately 91.5% |
| Top deep tech valuation vs. median | Approximately 1,000 times |
| Median deep tech valuation-to-capital-raised ratio | Approximately 3.8 times |
| Deep tech companies valued at $1B+ | 68 |
Top startups in the deep tech market ranked by valuation
Here is an updated table that ranks the top startups in the deep tech market based on their latest reported or estimated valuations.
| # | Startup Name | What They Do | Current Valuation ($) | Valuation Confidence Level | Valuation Type | Evidence Status | Total Funding ($) | Funding Confidence Level |
|---|---|---|---|---|---|---|---|---|
| 1 | SpaceX | Rockets, satellites, space internet | $2.0T | Full Confidence | Public Market Cap | Observed | $86.9B | Partial Confidence |
| 2 | Blue Origin | Rockets and space infrastructure | $120.0B–$140.0B | Partial Confidence | Active Raise Valuation | Estimated | Not provided | Low Confidence |
| 3 | Cambricon Technologies | Designs AI accelerator chips | $130.0B | Full Confidence | Public Market Cap | Observed | $1.3B | Partial Confidence |
| 4 | Figure AI | General-purpose humanoid robots | $39.0B | Full Confidence | Announced Private Round Valuation | Observed | $1.8B+ | Strong Confidence |
| 5 | Boston Dynamics | Builds advanced mobile robots | $20.0B–$24.0B | Partial Confidence | Proxy-Based Estimate | Estimated | Not provided | Low Confidence |
| 6 | IonQ | Trapped-ion quantum computing systems | $16.6B | Full Confidence | Public Market Cap | Observed | $3.1B | Strong Confidence |
| 7 | Isomorphic Labs | AI-powered drug design platform | $14.0B–$18.0B | Partial Confidence | Implied Valuation from Raise | Implied | $2.7B | Strong Confidence |
| 8 | Skild AI | General-purpose robotics foundation models | $14.0B–$14.5B | Strong Confidence | Announced Private Round Valuation | Observed | $1.8B | Strong Confidence |
| 9 | Shield AI | Autonomous defense aircraft software | $12.0B–$12.7B | Strong Confidence | Active Raise Valuation | Observed | $1.0B | Partial Confidence |
| 10 | Cerebras Systems | Builds wafer-scale AI computers | $12.5B | Full Confidence | Public Market Cap | Observed | $9.2B | Partial Confidence |
| 11 | Physical Intelligence | Develops foundation models for robots | $10.0B–$12.0B | Partial Confidence | Active Raise Valuation | Estimated | $1.9B | Partial Confidence |
| 12 | Colossal Biosciences | Develops de-extinction genetic technologies | $10.0B–$11.5B | Strong Confidence | Announced Private Round Valuation | Estimated | $435M | Full Confidence |
| 13 | Planet Labs | Operates daily Earth-imaging satellites | $9.4B | Full Confidence | Public Market Cap | Observed | $906M | Strong Confidence |
| 14 | Quantum Systems | Builds AI-enabled defense drones | $8.0B | Strong Confidence | Announced Private Round Valuation | Observed | $1.7B | Strong Confidence |
| 15 | Groq | AI inference chips and cloud | $6.9B–$8.5B | Strong Confidence | Implied Valuation from Raise | Implied | $1.8B | Strong Confidence |
| 16 | D-Wave Quantum | Builds quantum annealing systems | $7.8B | Full Confidence | Public Market Cap | Observed | $296M | Partial Confidence |
| 17 | Zipline | Autonomous drone delivery logistics | $7.6B | Full Confidence | Announced Private Round Valuation | Observed | $1.4B | Strong Confidence |
| 18 | PsiQuantum | Develops photonic fault-tolerant quantum computers | $7.0B | Strong Confidence | Announced Private Round Valuation | Observed | $1.7B | Partial Confidence |
| 19 | Unitree Robotics | Humanoid and quadruped robots | $6.0B–$8.0B | Partial Confidence | IPO or Listing Range Valuation | Estimated | $237M | Partial Confidence |
| 20 | Redwood Materials | Recycles batteries and produces materials | $6.0B–$6.3B | Strong Confidence | Announced Private Round Valuation | Observed | $2.2B | Strong Confidence |
| 21 | Symbotic | Warehouse robotics automation | $5.8B | Full Confidence | Public Market Cap | Observed | $725M | Low Confidence |
| 22 | Rigetti Computing | Builds superconducting quantum computers | $5.7B | Full Confidence | Public Market Cap | Observed | $278M | Strong Confidence |
| 23 | Apptronik | Builds humanoid robots | $5.0B–$5.8B | Strong Confidence | Announced Private Round Valuation | Observed | $1.0B | Strong Confidence |
| 24 | Lightmatter | Photonic interconnects for AI computing | $4.0B–$5.0B | Strong Confidence | Announced Private Round Valuation | Estimated | $850M | Strong Confidence |
| 25 | Firefly Aerospace | Launch and lunar spacecraft | $4.6B | Full Confidence | Public Market Cap | Observed | $1.5B | Partial Confidence |
| 26 | XtalPi | AI drug and materials discovery | $4.3B | Full Confidence | Public Market Cap | Observed | $785M | Partial Confidence |
| 27 | Geek+ | Autonomous warehouse mobile robots | $4.1B | Full Confidence | Public Market Cap | Observed | $880M | Partial Confidence |
| 28 | Relativity Space | Develops reusable heavy-lift rockets | $3.5B–$4.5B | Low Confidence | Proxy-Based Estimate | Estimated | $1.3B | Partial Confidence |
| 29 | Form Energy | Multi-day iron-air batteries | $3.4B–$4.4B | Partial Confidence | Active Raise Valuation | Estimated | $1.2B | Strong Confidence |
| 30 | SiFive | RISC-V processor intellectual property | $3.7B | Full Confidence | Announced Private Round Valuation | Observed | $765M | Strong Confidence |
| 31 | Xanadu | Photonic quantum computing systems | $3.4B | Full Confidence | Public Market Cap | Observed | $552M | Strong Confidence |
| 32 | Celestial AI | Photonic interconnects for AI infrastructure | $3.3B | Full Confidence | Acquisition Value | Observed | $581M | Strong Confidence |
| 33 | Tenstorrent | AI chips and RISC-V IP | $2.6B–$3.3B | Partial Confidence | Comparables-Based Estimate | Estimated | $1.0B | Strong Confidence |
| 34 | ArsenalBio | Engineers cancer cell therapies | $2.2B–$3.6B | Partial Confidence | Implied Valuation from Raise | Implied | $630M | Full Confidence |
| 35 | Insilico Medicine | AI drug discovery and development | $2.9B | Full Confidence | Public Market Cap | Observed | $518M | Strong Confidence |
| 36 | Astranis | Builds MicroGEO satellites | $2.7B–$2.9B | Strong Confidence | Announced Private Round Valuation | Observed | $808M | Strong Confidence |
| 37 | ElevateBio | Cell and gene therapy platform | $2.2B–$3.4B | Low Confidence | Implied Valuation from Raise | Estimated | $1.2B | Full Confidence |
| 38 | SambaNova Systems | Enterprise AI computing systems | $2.0B–$3.5B | Low Confidence | Implied Valuation from Raise | Estimated | $1.5B | Strong Confidence |
| 39 | Enflame Technology | Datacenter AI training chips | $2.3B–$2.8B | Partial Confidence | IPO or Listing Range Valuation | Estimated | $746M | Strong Confidence |
| 40 | Fourier Intelligence | Rehabilitation and humanoid robots | $1.2B–$3.9B | Low Confidence | Comparables-Based Estimate | Estimated | $234M | Partial Confidence |
| 41 | Agility Robotics | Warehouse humanoid robots | $2.4B–$2.6B | Strong Confidence | IPO or Listing Range Valuation | Observed | $641M | Partial Confidence |
| 42 | AbCellera | Discovers therapeutic antibodies | $2.5B | Full Confidence | Public Market Cap | Observed | $671M | Strong Confidence |
| 43 | Oxford Quantum Circuits | Builds superconducting quantum infrastructure | $2.0B–$2.9B | Partial Confidence | Implied Valuation from Raise | Implied | $499M | Full Confidence |
| 44 | Stoke Space | Fully reusable launch vehicles | $2.0B–$2.8B | Partial Confidence | Comparables-Based Estimate | Estimated | $480M | Full Confidence |
| 45 | True Anomaly | Autonomous space-security systems | $2.2B | Strong Confidence | Announced Private Round Valuation | Observed | $390M | Partial Confidence |
| 46 | Vast | Commercial orbital space stations | $1.8B–$2.5B | Partial Confidence | Implied Valuation from Raise | Implied | $1.0B | Partial Confidence |
| 47 | Exotec | Warehouse automation robot systems | $1.8B–$2.4B | Partial Confidence | Comparables-Based Estimate | Estimated | $446M | Strong Confidence |
| 48 | d-Matrix | Builds AI inference accelerators | $1.9B–$2.2B | Strong Confidence | Announced Private Round Valuation | Estimated | $450M | Strong Confidence |
| 49 | Axiom Space | Commercial space stations | $1.8B–$2.2B | Partial Confidence | Announced Private Round Valuation | Observed | $600M | Partial Confidence |
| 50 | Generate:Biomedicines | AI-designed protein therapeutics | $2.0B | Full Confidence | Public Market Cap | Observed | $1.1B | Strong Confidence |
| 51 | Recursion | Uses AI for drug discovery | $2.0B | Full Confidence | Public Market Cap | Observed | $1.2B | Strong Confidence |
| 52 | Pasqal | Builds neutral-atom quantum computers | $1.8B–$2.2B | Partial Confidence | IPO or Listing Range Valuation | Estimated | $335M | Strong Confidence |
| 53 | HawkEye 360 | Satellite radio-frequency intelligence | $1.9B | Full Confidence | Public Market Cap | Observed | $560M | Partial Confidence |
| 54 | Insitro | Machine-learning drug discovery platform | $1.5B–$2.2B | Low Confidence | Comparables-Based Estimate | Estimated | $643M | Full Confidence |
| 55 | Dexterity | Automates warehouse material handling | $1.5B–$1.9B | Strong Confidence | Announced Private Round Valuation | Estimated | $291M | Partial Confidence |
| 56 | Lyten | Lithium-sulfur batteries and graphene | $1.3B–$2.1B | Partial Confidence | Implied Valuation from Raise | Implied | $610M | Partial Confidence |
| 57 | EGenesis | Engineers transplantable animal organs | $1.3B–$2.0B | Partial Confidence | Implied Valuation from Raise | Implied | $454M | Strong Confidence |
| 58 | Sila Nanotechnologies | Silicon battery anode materials | $1.3B–$2.0B | Low Confidence | Proxy-Based Estimate | Estimated | $1.3B | Partial Confidence |
| 59 | Locus Robotics | Autonomous warehouse fulfillment robots | $1.3B–$1.8B | Partial Confidence | Comparables-Based Estimate | Estimated | $437M | Strong Confidence |
| 60 | QuEra Computing | Develops neutral-atom quantum systems | $1.5B–$2.3B | Partial Confidence | Implied Valuation from Raise | Implied | $247M | Partial Confidence |
| 61 | Infleqtion | Neutral-atom quantum systems | $1.4B | Full Confidence | Public Market Cap | Observed | $249M | Strong Confidence |
| 62 | Loft Orbital | Shared satellite infrastructure services | $1.1B–$1.4B | Strong Confidence | Announced Private Round Valuation | Estimated | $326M | Strong Confidence |
| 63 | Sana Biotechnology | Engineered cell therapies | $1.1B | Full Confidence | Public Market Cap | Observed | $1.6B | Partial Confidence |
| 64 | Black Sesame Technologies | Autonomous-driving AI chips | $1.1B | Full Confidence | Public Market Cap | Observed | $633M | Partial Confidence |
| 65 | IQM Quantum Computers | Superconducting quantum computing systems | $1.0B–$1.2B | Strong Confidence | Announced Private Round Valuation | Observed | $600M | Partial Confidence |
| 66 | Isar Aerospace | Small-satellite orbital launch vehicles | $900M–$1.3B | Partial Confidence | Implied Valuation from Raise | Estimated | $418M | Strong Confidence |
| 67 | Hailo | Low-power edge AI processors | $900M–$1.3B | Partial Confidence | Comparables-Based Estimate | Estimated | $341M | Full Confidence |
| 68 | Mujin | Intelligent industrial robot automation | $900M–$1.1B | Strong Confidence | Announced Private Round Valuation | Observed | $218M | Partial Confidence |
| 69 | Boston Metal | Emissions-free metals production | $850M–$1.1B | Partial Confidence | Implied Valuation from Raise | Estimated | $407M | Partial Confidence |
| 70 | Mammoth Biosciences | CRISPR therapeutics and diagnostics | $800M–$1.1B | Partial Confidence | Comparables-Based Estimate | Estimated | $263M | Strong Confidence |
| 71 | SEEQC | Digital quantum computing chips | $800M–$1.0B | Partial Confidence | Proxy-Based Estimate | Estimated | $64M | Partial Confidence |
| 72 | Atom Computing | Neutral-atom quantum computers | $750M–$1.1B | Partial Confidence | Implied Valuation from Raise | Implied | $180M | Strong Confidence |
| 73 | AMP Robotics | Recycling sortation automation | $650M–$950M | Partial Confidence | Implied Valuation from Raise | Implied | $268M | Strong Confidence |
| 74 | Alice & Bob | Cat-qubit quantum computers | $700M–$1.1B | Partial Confidence | Implied Valuation from Raise | Implied | $137M | Full Confidence |
| 75 | Lilac Solutions | Direct lithium extraction technology | $700M–$950M | Partial Confidence | Implied Valuation from Raise | Estimated | $316M | Strong Confidence |
| 76 | Quantum Machines | Quantum computing control systems | $650M–$800M | Partial Confidence | Announced Private Round Valuation | Estimated | $263M | Full Confidence |
| 77 | Collaborative Robotics | Adaptable collaborative robots | $550M–$800M | Partial Confidence | Implied Valuation from Raise | Implied | $140M | Full Confidence |
| 78 | Tessera Therapeutics | Gene-writing medicines platform | $550M–$800M | Low Confidence | Proxy-Based Estimate | Estimated | $580M | Strong Confidence |
| 79 | Alif Semiconductor | Edge AI chips | $450M–$800M | Low Confidence | Comparables-Based Estimate | Estimated | $186M | Partial Confidence |
| 80 | Graphcore | Intelligence processing AI chips | $600M | Strong Confidence | Acquisition Value | Observed | $682M | Partial Confidence |
| 81 | Ginkgo Bioworks | Programmable-cell biotechnology platform | $592M | Full Confidence | Public Market Cap | Observed | $2.4B | Strong Confidence |
| 82 | Classiq | Quantum software platform | $480M–$600M | Strong Confidence | Announced Private Round Valuation | Estimated | $180M | Strong Confidence |
| 83 | The Exploration Company | Reusable orbital cargo capsules | $450M–$650M | Partial Confidence | Comparables-Based Estimate | Estimated | $210M | Full Confidence |
| 84 | GreyOrange | Warehouse robotics and orchestration | $400M–$700M | Partial Confidence | Comparables-Based Estimate | Estimated | $480M | Partial Confidence |
| 85 | D-Orbit | In-space logistics services | $425M–$600M | Partial Confidence | Implied Valuation from Raise | Estimated | $219M | Partial Confidence |
| 86 | Solid Power | Solid-state electric-vehicle batteries | $522M | Full Confidence | Public Market Cap | Observed | $750M | Partial Confidence |
| 87 | Riverlane | Quantum error-correction systems | $375M–$625M | Partial Confidence | Implied Valuation from Raise | Implied | $118M | Full Confidence |
| 88 | Quandela | Photonic quantum computing systems | $300M–$500M | Low Confidence | Comparables-Based Estimate | Estimated | $71M | Strong Confidence |
| 89 | Covariant | Robotic foundation models | $300M–$550M | Low Confidence | Proxy-Based Estimate | Estimated | $222M | Full Confidence |
| 90 | Berkshire Grey | Warehouse robotic automation | $375M | Full Confidence | Acquisition Value | Observed | $676M | Partial Confidence |
| 91 | ANYbotics | Inspection robot dogs | $250M–$450M | Partial Confidence | Comparables-Based Estimate | Estimated | $152M | Strong Confidence |
| 92 | Kneron | Edge AI processors and software | $250M–$400M | Low Confidence | Comparables-Based Estimate | Estimated | $170M | Partial Confidence |
| 93 | Capella Space | Radar-imaging satellites | $310M | Full Confidence | Acquisition Value | Observed | $176M | Partial Confidence |
| 94 | Astrobotic | Lunar robotics and landers | $300M | Strong Confidence | Acquisition Value | Observed | $3M | Low Confidence |
| 95 | Sanctuary AI | General-purpose humanoid robots | $220M–$350M | Low Confidence | Comparables-Based Estimate | Estimated | $100M | Partial Confidence |
| 96 | Metagenomi | Gene-editing therapeutic technologies | $47M | Full Confidence | Public Market Cap | Observed | $444M | Full Confidence |
| 97 | Universal Quantum | Trapped-ion quantum computer hardware | $25M–$50M | Low Confidence | Proxy-Based Estimate | Estimated | $5M | Partial Confidence |
Key valuation trends in the deep tech market
Insights
- SpaceX accounts for roughly 76% of the combined valuation in this deep tech ranking, showing how one scaled space platform can reshape the economics of an otherwise diverse market.
- Figure AI, Skild AI and Apptronik carry approximately $59 billion in combined valuation after raising about $4.6 billion, reflecting the premium investors place on general-purpose humanoid robotics.
- IonQ, Rigetti Computing, Infleqtion and Xanadu represent approximately $27 billion in public quantum computing value, compared with about $4.2 billion in identified funding.
- Colossal Biosciences has a valuation above $10 billion after raising $435 million, producing a valuation-to-funding ratio of roughly 25 times at the midpoint.
- Planet Labs has a market capitalization of about $9.4 billion, more than ten times its identified funding, which makes Planet Labs a notable capital-efficiency result in space infrastructure.
- Groq and Skild AI have each raised about $1.8 billion, but Skild AI commands nearly twice Groq's midpoint valuation, suggesting a stronger current premium for robotics foundation models.
- Celestial AI's $3.3 billion acquisition value equals roughly 5.7 times its identified funding, highlighting the strategic importance of photonic interconnects for AI datacenter expansion.
- Deep tech public markets show severe outcome dispersion. AbCellera remains valued near $2.5 billion, while Ginkgo Bioworks and Metagenomi trade far below the capital invested in the companies.
- SiFive's $3.7 billion valuation is almost five times its $765 million funding, showing how RISC-V intellectual property can create infrastructure-like value without owning semiconductor fabrication plants.
- Warehouse robotics has produced mixed outcomes. Exotec and Locus Robotics remain valued at several times funding, while Berkshire Grey's acquisition value fell below its cumulative capital raised.
A few word about our methodology
As you can see, we built a database that ranks startups and technology companies in the deep tech market based on their current valuation.
Estimating deep tech startup valuations is not always straightforward. Many companies do not publicly disclose their valuation, and available information can vary widely by company, technology and stage.
Deep tech companies can also require long development periods, specialized facilities, regulatory approvals and significant research spending. These factors make simple comparisons difficult.
To build this ranking, we applied a structured valuation methodology and cross-checked information across multiple reliable sources.
Whenever possible, we relied on direct disclosures. These include announced valuations from completed funding rounds, public filings for listed companies and official acquisition prices.
When a deep tech company is publicly listed, we use its current market capitalization as the reference valuation.
If a company was acquired and no independent valuation can reasonably be estimated today, we use the acquisition price as the main reference point.
When a startup recently raised capital but the valuation was not disclosed, we estimate the implied valuation using typical dilution levels for that stage of fundraising.
In some cases, we estimate valuations using operating metrics such as revenue, contracted orders, annual recurring revenue, commercial deployments or customer traction.
We combine these metrics with valuation multiples from comparable companies in the same deep tech segment.
The relevant comparison depends on the company. A quantum computing startup requires a different framework from a biotechnology platform, a semiconductor company or a commercial space business.
When direct financial data is not available, we may use carefully selected comparable startups and other signals such as hiring growth, investor quality, patents, technical milestones, manufacturing progress or product adoption.
All estimates follow a strict evidence hierarchy. Recent funding rounds with announced valuations carry the most weight, followed by strong operating metrics and comparable company analysis.
We also evaluate the age of every data point. Recent information carries more weight, while older information is treated cautiously and adjusted conservatively when necessary.
Whenever information is uncertain or incomplete, we clearly distinguish between confirmed facts and reasonable inferences.
Because valuation data is not always fully public, each company in the ranking is assigned a confidence level based on the reliability, recency and consistency of the available evidence.
Full confidence means the valuation is supported by strong and recent evidence. Strong confidence means the estimate is well supported but includes minor inference. Partial confidence means the estimate relies more heavily on indirect signals. Low confidence means available information is limited or inconsistent.
When confidence is lower, we take a more conservative approach by widening the valuation range. This reflects the uncertainty and increases the probability that the true valuation falls within the estimated range.
In a world where LLMs hallucinate and unreliable information is everywhere, our goal is simple: provide data you can trust.
If you want the full detail on a specific valuation estimate, feel free to contact us and we will gladly explain.
Finally, know that we update the dataset once per month, so come back here if you need fresh information.
Related blog posts
- What are the key fundraising trends in the deep tech market?
- The most heavily funded startups in the deep tech market
- What does funding activity look like in the deep tech market?
- A complete overview of funding deals in the deep tech market
Who is the author of this content?
NEW MARKET PITCH TEAM
We track new markets so founders and investors can move fasterWe build living “market pitch” documents for emerging markets: from AI to synthetic biology and new proteins. Instead of digging through outdated PDFs, random blog posts, and hallucinated LLM answers, our clients get a clean, visual, always-updated view of what’s really happening. We map the key players, deals, regulations, metrics and signals that matter so you can decide faster whether a market is worth your time. Want to know more? Check out our about page. You can also follow us on Instagram or on Facebook.
How we created this content 🔎📝
At New Market Pitch, we kept seeing the same problem: when you look at a new market, the data is either missing, paywalled, or buried in 300-page reports that feel like they were written in the 80s. On the other side, LLMs and random blog posts give you confident answers with no sources, and sometimes they just make things up. That’s not good enough when you’re about to invest real money or launch a company.
So we decided to fix the experience. For each market we cover, we build a structured database and update it on a regular basis. We track funding rounds, fund memos, M&A moves, partnerships, new products, policy changes, and the real activity of startups and incumbents. Then we turn all of that into a clear “market pitch” that shows where the opportunities are and how people actually win in that space.
Every key data point is checked, sourced, and put back into context by our team. That’s how we can give you both speed and reliability: fast coverage of new markets, without the usual guesswork.